Mental Health Disorders
Mental health disorders affect individuals of all ages and can significantly impact their quality of life, productivity, and social interactions. Early screening, proper management, preventive strategies, and timely referrals are crucial for effective mental health care.
πΉ Objective:
πΉ Common Mental Health Disorders Requiring Screening:
β
Depression & Anxiety Disorders
β
Schizophrenia & Psychotic Disorders
β
Bipolar Disorder
β
Post-Traumatic Stress Disorder (PTSD)
β
Obsessive-Compulsive Disorder (OCD)
β
Substance Use Disorders (Alcohol, Drugs)
β
Neurocognitive Disorders (Dementia, Alzheimerβs Disease)
πΉ Screening Tools Used by Healthcare Providers:
Disorder | Screening Tool | Method |
---|---|---|
Depression | PHQ-9 (Patient Health Questionnaire) | Self-report, clinical interview |
Anxiety Disorders | GAD-7 (Generalized Anxiety Disorder Scale) | Questionnaire-based |
Bipolar Disorder | MDQ (Mood Disorder Questionnaire) | Interview-based assessment |
Schizophrenia & Psychosis | PANSS (Positive and Negative Syndrome Scale) | Observation & patient history |
Substance Use Disorder | CAGE Questionnaire, AUDIT (Alcohol Use Disorders Identification Test) | Screening for alcohol and drug abuse |
Dementia & Alzheimerβs | MMSE (Mini-Mental State Examination) | Cognitive assessment |
PTSD | PCL-5 (PTSD Checklist) | Patient interview |
OCD | Y-BOCS (Yale-Brown Obsessive Compulsive Scale) | Questionnaire-based |
πΉ Nurseβs Role in Screening:
β
Conduct community-based mental health screenings at PHCs, schools, workplaces, and elderly care centers.
β
Identify early symptoms such as mood swings, withdrawal, hallucinations, suicidal ideation, and cognitive decline.
β
Educate families and caregivers about signs of mental illness.
β
Assess risk factors such as stress, trauma, genetics, and substance use.
β
Refer high-risk individuals for further psychiatric evaluation if needed.
πΉ Objective:
πΉ Key Management Approaches:
β
Antidepressants (e.g., SSRIs, SNRIs) β For depression and anxiety.
β
Antipsychotics (e.g., Risperidone, Olanzapine) β For schizophrenia and bipolar disorder.
β
Mood Stabilizers (e.g., Lithium, Valproate) β For bipolar disorder.
β
Anxiolytics (e.g., Benzodiazepines) β For severe anxiety and panic disorders.
β
Cognitive Enhancers (e.g., Donepezil, Memantine) β For dementia.
πΉ Role of a Nurse in Medication Management:
β
Ensure adherence to prescribed medications.
β
Monitor side effects and interactions.
β
Educate patients on proper medication use and withdrawal risks.
β
Encourage regular follow-ups with psychiatrists.
β
Cognitive Behavioral Therapy (CBT) β Helps with depression, anxiety, OCD.
β
Dialectical Behavior Therapy (DBT) β Beneficial for personality disorders and self-harm behaviors.
β
Exposure Therapy β Used for PTSD and phobias.
β
Motivational Interviewing β Helps in substance use disorders.
β
Family Therapy β Supports caregivers and improves home environments.
πΉ Nurseβs Role in Counseling:
β
Conduct one-on-one or group therapy sessions.
β
Help patients identify negative thoughts and behaviors.
β
Provide emotional support and coping strategies.
β
Teach relaxation techniques (breathing exercises, meditation, mindfulness).
β
Exercise & Physical Activity β Reduces stress and depression symptoms.
β
Balanced Diet β Supports brain function and mood stabilization.
β
Sleep Hygiene β Improves cognitive health and emotional regulation.
β
Avoiding Substance Use β Prevents relapse in addiction disorders.
β
Social Engagement β Reduces isolation and enhances emotional well-being.
πΉ Nurseβs Role in Lifestyle Modifications:
β
Promote healthy sleep routines.
β
Educate on the benefits of physical activity.
β
Guide on nutritional choices for mental health.
β
Support self-help groups and community integration.
πΉ Objective:
πΉ Levels of Prevention:
β
Community Education Programs β Awareness on stress management, positive mental health habits.
β
School Mental Health Programs β Prevent bullying, academic stress, anxiety in students.
β
Workplace Wellness Initiatives β Promote work-life balance and reduce job-related stress.
β
Mental Health Screening Camps at primary health centers and community levels.
β
Suicide Prevention Helplines & Crisis Support.
β
Early counseling for trauma victims to prevent PTSD.
β
Long-term therapy and support groups for psychiatric patients.
β
Rehabilitation centers for addiction and substance use disorders.
β
Job placement and vocational training for individuals with mental illness.
πΉ Nurseβs Role in Prevention:
β
Educate families on mental well-being and coping mechanisms.
β
Promote early childhood mental health programs.
β
Train teachers, caregivers, and community leaders in mental health awareness.
β
Reduce stigma associated with mental illnesses.
πΉ Objective:
πΉ When to Refer a Patient?
β
Persistent suicidal thoughts or self-harm.
β
Severe psychotic symptoms (hallucinations, delusions, disorganized thinking).
β
Uncontrolled aggressive or violent behavior.
β
Failure of first-line treatment for depression, anxiety, or bipolar disorder.
β
Cognitive decline affecting daily life (Alzheimerβs, Dementia).
πΉ Referral Pathway:
Healthcare Level | Services Provided | Referral Centers |
---|---|---|
Primary Level (PHC, CHC, Clinics) | Basic screening, counseling, medication initiation | Psychiatric OPD at District Hospital |
Secondary Level (District Hospital, General Hospital) | Inpatient psychiatric care, advanced treatment | Regional Mental Health Institutes |
Tertiary Level (Specialty Mental Health Hospitals, Institutes) | Electroconvulsive Therapy (ECT), Advanced Psychotherapy, Rehabilitation | NIMHANS, AIIMS, CIP Ranchi |
πΉ Key Mental Health Institutions in India:
π₯ NIMHANS (National Institute of Mental Health and Neurosciences), Bengaluru
π₯ Central Institute of Psychiatry (CIP), Ranchi
π₯ Institute of Human Behavior and Allied Sciences (IHBAS), Delhi
π₯ Regional Mental Health Centers in Various States
REVIEW OF MENTAL HEALTH DISORDERS.
Mental health disorders such as depression, anxiety, and acute psychosis affect millions of people globally. These conditions impact emotions, thoughts, and behaviors and require timely diagnosis, management, and appropriate treatment to improve the individual’s quality of life.
Depression is a mood disorder characterized by persistent sadness, loss of interest in activities, and impaired daily functioning.
β
Biological Factors: Neurotransmitter imbalances (Serotonin, Dopamine, Norepinephrine).
β
Genetic Factors: Family history of depression.
β
Psychosocial Factors: Trauma, abuse, stress, relationship problems.
β
Chronic Medical Conditions: Diabetes, cardiovascular diseases, thyroid disorders.
β
Substance Abuse: Alcohol, drugs, and certain medications.
β Emotional Symptoms:
β Cognitive Symptoms:
β Physical Symptoms:
πΉ Major Depressive Disorder (MDD): Persistent low mood lasting β₯2 weeks.
πΉ Persistent Depressive Disorder (Dysthymia): Chronic depression lasting β₯2 years.
πΉ Postpartum Depression: Depression occurring after childbirth.
πΉ Seasonal Affective Disorder (SAD): Depression linked to seasonal changes.
πΉ Bipolar Depression: Depressive episodes in Bipolar Disorder.
β
Clinical Interview & History Taking.
β
Screening Tools:
πΉ Pharmacological Treatment:
β
Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline.
β
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Duloxetine.
β
Tricyclic Antidepressants (TCAs): Amitriptyline, Imipramine.
β
Monoamine Oxidase Inhibitors (MAOIs): Phenelzine, Tranylcypromine (used in resistant cases).
πΉ Psychotherapy:
β
Cognitive Behavioral Therapy (CBT): Corrects negative thought patterns.
β
Interpersonal Therapy (IPT): Helps improve relationship issues.
β
Mindfulness Therapy: Focuses on stress reduction and relaxation techniques.
πΉ Lifestyle Modifications:
β
Regular exercise, healthy diet, good sleep hygiene.
β
Social engagement & support groups.
β
Avoiding alcohol and drugs.
πΉ Electroconvulsive Therapy (ECT):
Anxiety disorders involve excessive worry, fear, or nervousness that interferes with daily activities.
β
Neurotransmitter Imbalance: Low GABA, Serotonin, Dopamine.
β
Genetic & Family History: Increased risk if close relatives have anxiety disorders.
β
Personality Traits: Perfectionism, low self-esteem.
β
Medical Conditions: Thyroid disorders, cardiovascular diseases.
β Emotional Symptoms:
β Cognitive Symptoms:
β Physical Symptoms:
πΉ Generalized Anxiety Disorder (GAD): Persistent worry about multiple things.
πΉ Panic Disorder: Sudden panic attacks with intense fear.
πΉ Social Anxiety Disorder: Fear of embarrassment in social settings.
πΉ Phobias: Intense fear of specific objects or situations.
πΉ Obsessive-Compulsive Disorder (OCD): Repetitive thoughts and behaviors.
πΉ Post-Traumatic Stress Disorder (PTSD): Anxiety after trauma.
β Screening Tools:
πΉ Pharmacological Treatment:
β
Benzodiazepines: Alprazolam, Lorazepam (short-term use).
β
SSRIs & SNRIs: Fluoxetine, Paroxetine, Venlafaxine.
β
Beta-blockers (Propranolol): For physical symptoms like palpitations.
πΉ Psychotherapy:
β
CBT: Changes negative thought patterns and coping skills.
β
Exposure Therapy: Helps with phobias and PTSD.
β
Relaxation Techniques: Yoga, meditation, deep breathing.
πΉ Lifestyle Changes:
β
Reduce caffeine intake, improve sleep, engage in regular exercise.
β
Journaling & relaxation techniques.
Acute psychosis is a severe mental state in which a person loses contact with reality, experiencing hallucinations, delusions, and disorganized thinking.
β
Schizophrenia Spectrum Disorders.
β
Substance-Induced Psychosis (Alcohol, Cannabis, LSD, Cocaine).
β
Bipolar Disorder with Psychotic Features.
β
Severe Depression (Psychotic Depression).
β
Medical Conditions (Brain Tumors, Dementia, Infections, Stroke, Epilepsy).
β
Hallucinations: Seeing, hearing, or feeling things that are not real.
β
Delusions: False beliefs (e.g., paranoia, grandiosity).
β
Disorganized Speech & Thinking: Jumping from topic to topic.
β
Catatonia: Lack of movement or extreme agitation.
β
Aggression or Self-Harm Risk: In some cases.
β
Mental Status Examination (MSE).
β
Brief Psychiatric Rating Scale (BPRS).
β
Neurological Screening & Toxicology Tests.
πΉ Emergency Stabilization:
β
Hospitalization for safety if aggressive or suicidal.
β
Sedation (Lorazepam, Haloperidol IM) if severely agitated.
πΉ Pharmacological Treatment:
β
Antipsychotics: Olanzapine, Risperidone, Haloperidol.
β
Mood Stabilizers (Lithium, Valproate) for Bipolar Psychosis.
πΉ Psychosocial Support & Rehabilitation:
β
Family education & caregiver support.
β
Long-term therapy for schizophrenia & bipolar disorder.
Schizophrenia is a chronic and severe mental disorder that affects a person’s thinking, emotions, perception, and behavior. It is characterized by delusions, hallucinations, disorganized speech, and impaired social functioning.
πΉ Prevalence: Affects about 1% of the global population.
πΉ Onset: Typically begins between late adolescence and early adulthood (15-30 years old).
πΉ Course: Can be episodic or continuous, requiring lifelong management.
β Neurotransmitter Imbalance:
β Genetic Factors:
β Brain Structure Abnormalities:
β Prenatal Exposure:
β Psychosocial Stressors:
β Substance Abuse:
Schizophrenia is categorized into three main symptom groups:
β Hallucinations:
β Delusions:
β Disorganized Speech:
β Disorganized Behavior:
β Catatonia:
β
Apathy: Lack of motivation to do daily activities.
β
Anhedonia: Loss of interest in pleasurable activities.
β
Alogia: Reduced speech output.
β
Social Withdrawal: Avoidance of social interactions.
β
Flat Affect: No emotional expressions or response.
β
Impaired attention & concentration.
β
Memory problems.
β
Poor problem-solving ability.
β
Difficulty understanding abstract concepts.
πΉ Paranoid Schizophrenia:
πΉ Disorganized Schizophrenia:
πΉ Catatonic Schizophrenia:
πΉ Undifferentiated Schizophrenia:
πΉ Residual Schizophrenia:
πΉ At least 2 of the following symptoms must be present for at least 6 months:
β
Delusions
β
Hallucinations
β
Disorganized speech
β
Disorganized behavior or catatonia
β
Negative symptoms (e.g., apathy, social withdrawal)
β
Mental Status Examination (MSE): Observing speech, thoughts, perception.
β
Positive and Negative Syndrome Scale (PANSS): Measures symptom severity.
β
Brief Psychiatric Rating Scale (BPRS): Assesses psychotic symptoms.
β
MRI/CT Scan: To rule out brain tumors or structural abnormalities.
β
EEG: To rule out epilepsy.
β
Toxicology Screening: To rule out drug-induced psychosis.
β First-Generation (Typical) Antipsychotics:
β Second-Generation (Atypical) Antipsychotics:
β Clozapine: Used for treatment-resistant schizophrenia but requires regular blood monitoring for agranulocytosis.
β Long-Acting Injectable Antipsychotics (Depot Injections):
β
Cognitive Behavioral Therapy (CBT): Helps manage delusions and hallucinations.
β
Family Therapy: Educates families on supporting the patient.
β
Social Skills Training: Helps with employment and relationships.
β
Assertive Community Treatment (ACT): Mobile mental health teams provide home-based care.
β
Regular sleep schedule & daily routine.
β
Balanced diet & physical activity.
β
Avoid substance abuse (alcohol, drugs).
β
Vocational training for independent living.
β
Crisis intervention & suicide prevention strategies.
β
Failure of outpatient treatment.
β
Severe aggression, suicidal risk, or catatonia.
β
Medication non-adherence or poor family support.
β
Comorbid medical conditions requiring specialized care.
π₯ Primary Level: Community mental health programs, counseling centers.
π₯ Secondary Level: District hospitals with psychiatric wards.
π₯ Tertiary Level: National mental health institutes (e.g., NIMHANS, CIP Ranchi, IHBAS Delhi).
πΉ Early diagnosis and treatment improve prognosis.
πΉ 60-70% of patients show significant improvement with medication.
πΉ 20% achieve full recovery, while others may need lifelong treatment.
πΉ Medication non-compliance leads to relapse in >50% of cases.
Dementia is a progressive neurological disorder that leads to cognitive decline, memory loss, and impaired daily functioning. It is not a disease itself but a syndrome caused by various brain disorders, including Alzheimerβs disease, vascular dementia, and Lewy body dementia.
β Neurodegenerative Disorders:
β Vascular Factors:
β Genetic Factors:
β Lifestyle & Environmental Factors:
β
Memory loss (especially recent events).
β
Confusion and disorientation.
β
Difficulty with problem-solving and judgment.
β
Personality changes, aggression, anxiety, hallucinations.
β
Depression and social withdrawal.
β
Impaired balance and coordination.
β
Difficulty swallowing (late-stage dementia).
Type | Cause | Key Features |
---|---|---|
Alzheimerβs Disease | Amyloid plaques & tau tangles | Progressive memory loss, confusion |
Vascular Dementia | Stroke, reduced blood flow | Stepwise cognitive decline |
Lewy Body Dementia | Abnormal protein deposits | Hallucinations, fluctuating cognition |
Frontotemporal Dementia | Frontal lobe atrophy | Personality & behavior changes |
β
Clinical History & Mental Status Exam
β
Mini-Mental State Examination (MMSE)
β
Montreal Cognitive Assessment (MoCA)
β
MRI & CT Scan β To detect brain atrophy or vascular damage.
β
Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine (for mild to moderate Alzheimerβs).
β
NMDA Receptor Antagonists: Memantine (for moderate to severe dementia).
β
Antipsychotics & Mood Stabilizers for behavioral issues (Risperidone, Quetiapine).
β
Cognitive Therapy: Memory training, reality orientation therapy.
β
Behavioral Interventions: Reducing agitation, music therapy.
β
Physical Activity & Social Engagement.
β
Nutritional support (high-caloric diet for weight loss cases).
β
Home safety modifications (fall prevention, removing sharp objects).
β
Caregiver education & respite care.
Suicide is the deliberate act of taking oneβs own life. It is often associated with mental health disorders, stress, and social issues.
β Psychiatric Disorders:
β Social & Environmental Factors:
β Medical Conditions:
β Previous Suicide Attempts:
β Childhood Trauma & Abuse:
πΉ Verbal Cues:
β
Expressing hopelessness, worthlessness, or a burden to others.
β
Talking about wanting to die or having no reason to live.
πΉ Behavioral Changes:
β
Giving away possessions, sudden withdrawal from social activities.
β
Increased substance use, reckless behavior.
πΉ Emotional Signs:
β
Intense sadness, sudden mood swings.
β
Lack of interest in previously enjoyed activities.
β
Columbia Suicide Severity Rating Scale (C-SSRS).
β
Suicidal Ideation Questionnaire (SIQ).
β
Patient Health Questionnaire (PHQ-9) β For depression-related suicide risk.
πΉ High-Risk Indicators:
β
Suicidal thoughts with a plan & means to act.
β
Past history of suicide attempts.
β
No social support system.
β
Immediate hospitalization for active suicide risk.
β
Ensure safety β Remove sharp objects, firearms, toxic substances.
β
Provide constant supervision (1:1 monitoring if needed).
β
Rapid stabilization with medications if necessary.
β
Antidepressants (SSRIs, SNRIs) for underlying depression.
β
Mood stabilizers (Lithium, Valproate) for bipolar disorder.
β
Antipsychotics for schizophrenia-related suicide risk.
β
Cognitive Behavioral Therapy (CBT) β Reduces suicidal ideation.
β
Dialectical Behavior Therapy (DBT) β Effective for borderline personality disorder.
β
Crisis Helplines & Support Groups β Immediate emotional support.
β
Follow-up psychiatric care & regular therapy sessions.
β
Family & caregiver education on suicide warning signs.
β
Encourage engagement in social and recreational activities.
β
Substance abuse treatment if applicable.
Condition | Referral Centers |
---|---|
Dementia | Neurologists, Memory Clinics, Geriatric Psychiatrists |
Suicidal Patients | Psychiatric Emergency Units, Crisis Helplines, Suicide Prevention Clinics |
πΉ National Suicide Prevention Helplines (India):
β
Vandrevala Foundation Helpline β 1860 266 2345
β
AASRA Helpline β 91-9820466726
β
Snehi Suicide Prevention β 91-9582208181
Alcohol and substance abuse refers to the habitual and harmful use of psychoactive substances such as alcohol, tobacco, opioids, cannabis, and other drugs, leading to physical, psychological, and social consequences.
Substance | Effects | Health Risks |
---|---|---|
Alcohol | Depressant, relaxation | Liver disease, pancreatitis, heart problems |
Tobacco/Nicotine | Stimulant, alertness | Lung cancer, heart disease |
Opioids (Heroin, Morphine, Codeine, Fentanyl) | Pain relief, euphoria | Respiratory depression, addiction |
Cannabis (Marijuana, Hashish, THC products) | Euphoria, altered perception | Cognitive impairment, psychosis |
Cocaine | Intense euphoria, energy boost | Heart attack, stroke, paranoia |
Amphetamines (Meth, Ecstasy) | Hyperactivity, alertness | Hypertension, psychosis |
Hallucinogens (LSD, PCP, Psilocybin Mushrooms) | Altered perception, hallucinations | Panic attacks, psychotic episodes |
Inhalants (Glue, Paint Thinner, Gasoline, Nitrous Oxide) | Euphoria, dizziness | Brain damage, respiratory failure |
β
Genetic Factors: Family history of substance abuse.
β
Psychosocial Factors: Peer pressure, stress, trauma, social isolation.
β
Mental Health Disorders: Depression, anxiety, schizophrenia.
β
Environmental Factors: Easy drug availability, lack of supervision.
β
Chronic Pain & Prescription Drug Use: Opioid addiction from painkillers.
β
Liver damage (alcoholic cirrhosis, hepatitis).
β
Increased risk of infections (HIV/AIDS, Hepatitis B & C from shared needles).
β
Heart disease, stroke, high blood pressure.
β
Cancer (lung, liver, throat).
β
Depression, anxiety, paranoia.
β
Memory loss, confusion, hallucinations.
β
Violent/aggressive behavior.
β
Family conflicts, domestic violence.
β
Unemployment, financial instability.
β
Legal issues (drunk driving, drug possession).
πΉ Implemented by Ministry of Social Justice and Empowerment (MSJE).
πΉ Aims to prevent drug abuse, provide treatment, and rehabilitate individuals.
πΉ Focus on awareness, deaddiction centers, capacity building.
β Prevention and Awareness
β Treatment and Rehabilitation
β Law Enforcement & Policy Implementation
πΉ Integrated Rehabilitation Centres for Addicts (IRCAs)
πΉ National Drug Dependence Treatment Centre (NDDTC) β AIIMS, New Delhi
πΉ State-Level Deaddiction Centers
πΉ Community-Based Rehabilitation
πΉ Step 1: Screening & Assessment
β
Identifying addiction severity using Addiction Severity Index (ASI).
β
Conducting physical & mental health evaluations.
πΉ Step 2: Detoxification (Withdrawal Management)
β
Supervised withdrawal in medical settings.
β
Medications for withdrawal symptoms:
πΉ Step 3: Psychological Therapy
β
Cognitive Behavioral Therapy (CBT): Helps recognize & change addiction triggers.
β
Motivational Interviewing (MI): Encourages change in behavior.
β
Group Therapy & Peer Support (AA, NA meetings).
πΉ Step 4: Medication-Assisted Treatment (MAT)
β
Alcohol Addiction: Disulfiram (causes unpleasant reaction if alcohol is consumed).
β
Opioid Addiction: Methadone, Naltrexone, Buprenorphine.
πΉ Step 5: Rehabilitation & Relapse Prevention
β
Long-term social support, vocational training, and follow-up counseling.
π National Drug Deaddiction Helpline: 1800-11-0031
π Alcoholics Anonymous (AA) India: +91 90225 33612
π Narcotics Anonymous (NA) India: +91 98182 22405
Role | Responsibilities |
---|---|
Screening & Assessment | Identify addiction severity, monitor withdrawal symptoms |
Detoxification Support | Administer withdrawal medications, prevent complications |
Counseling & Motivation | Educate patients & families, promote relapse prevention |
Rehabilitation Support | Assist in social reintegration, vocational training |
Community Awareness | Conduct drug education programs in schools, workplaces |
The National Mental Health Programme (NMHP) was launched by the Government of India in 1982 to address the significant burden of mental health issues and the shortage of qualified professionals in the country. It aims to integrate mental health services into the general healthcare system, ensuring accessibility and availability for all.
The primary objectives of the NMHP are:
The NMHP encompasses several key components:
Achievements:
Challenges:
India’s first National Mental Health Policy was introduced in 2014, reflecting the government’s commitment to addressing mental health issues comprehensively. The policy adopts a rights-based approach, emphasizing the protection and promotion of the rights of individuals with mental illnesses.
The policy’s vision includes:
The policy outlines strategic areas such as:
The Mental Healthcare Act, 2017 was enacted to provide a robust legal framework for mental health services in India. It emphasizes the rights of individuals with mental illnesses and aligns with international conventions, particularly the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD).
The Act ensures several rights, including:
Implementation:
Challenges:
A Community Health Nurse (CHN) plays a vital role in identifying, managing, and supporting individuals with mental health disorders at the community level. The nurse is often the first point of contact for individuals with mental illnesses and helps in early detection, treatment initiation, and long-term follow-up.
πΉ Objective:
πΉ Common Mental Health Conditions Requiring Screening:
β
Depression
β
Anxiety disorders (GAD, PTSD, OCD, phobias)
β
Schizophrenia and other psychotic disorders
β
Bipolar disorder
β
Substance use disorders (alcohol, drugs)
β
Dementia and Alzheimerβs disease
β
Suicidal ideation
πΉ Screening Tools Used by Community Health Nurses:
Disorder | Screening Tool | Method |
---|---|---|
Depression | PHQ-9 (Patient Health Questionnaire) | Questionnaire |
Anxiety Disorders | GAD-7 (Generalized Anxiety Disorder Scale) | Self-report assessment |
Schizophrenia | PANSS (Positive and Negative Syndrome Scale) | Clinical interview |
Substance Use Disorder | CAGE-AID Questionnaire | Self-report survey |
Suicidal Risk | Columbia-Suicide Severity Rating Scale (C-SSRS) | Patient interview |
Dementia | MMSE (Mini-Mental State Examination) | Cognitive assessment |
πΉ Community Health Nurseβs Responsibilities in Screening:
β
Conduct mental health screenings in schools, workplaces, community centers, and PHCs.
β
Identify early warning signs such as social withdrawal, mood changes, or delusions.
β
Educate families and caregivers to recognize symptoms in their loved ones.
β
Ensure privacy and confidentiality to build patient trust.
β
Refer high-risk individuals to psychiatrists, psychologists, or deaddiction centers.
πΉ Objective:
β
Provide emotional support and reassurance to mentally ill clients.
β
Educate patients and families on mental health conditions and treatment options.
β
Use basic counseling techniques to help manage stress and emotional distress.
β
Educate clients about proper medication use, side effects, and adherence.
β
Administer psychotropic drugs (antidepressants, antipsychotics, mood stabilizers) under supervision.
β
Observe for adverse drug reactions and complications.
β
Identify and intervene in psychiatric emergencies (suicidal ideation, aggression, psychotic breakdowns).
β
Arrange urgent referrals for hospitalization when needed.
β
Assist in electroconvulsive therapy (ECT) referrals for severe depression or schizophrenia.
β
Help clients regain basic life skills, employment, and social relationships.
β
Guide families in creating a supportive home environment.
β
Encourage participation in self-help groups, therapy sessions, and community activities.
πΉ Objective:
β
Monitor medication adherence and side effects.
β
Assess behavioral changes, social interactions, and progress.
β
Address relapses, substance use relapse, or worsening symptoms.
β
Provide ongoing psychoeducation to clients and families.
β
Teach early warning signs of relapse and how to manage them.
β
Encourage stress management techniques (yoga, meditation, deep breathing exercises).
β
Help clients develop coping mechanisms for social interactions and employment challenges.
β
Educate families on how to handle crises and support recovery.
β
Arrange caregiver training programs.
β
Promote support groups for families to share experiences and seek help.
β
Refer patients for specialist care in case of severe symptoms.
β
Coordinate with psychiatrists, psychologists, occupational therapists.
β
Arrange social welfare benefits (disability pensions, free medication schemes).
β District Mental Health Programme (DMHP):
β National Mental Health Programme (NMHP):
β Suicide Prevention & Crisis Intervention Programs:
β Alcohol & Drug Deaddiction Services:
Function | Responsibilities |
---|---|
Screening | Conducts mental health assessments, identifies early symptoms. |
Counseling | Provides emotional support, educates families. |
Medication Management | Ensures adherence, monitors side effects. |
Crisis Intervention | Handles psychiatric emergencies, coordinates urgent referrals. |
Rehabilitation | Encourages social reintegration, skill-building. |
Relapse Prevention | Monitors progress, educates on stress management. |
Family & Community Engagement | Reduces stigma, trains caregivers. |